USD 303.32
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 57.2 Billion CHF | 1.9% |
2022 | 56.13 Billion CHF | -12.25% |
2021 | 63.97 Billion CHF | 37.97% |
2020 | 46.36 Billion CHF | -1.82% |
2019 | 47.22 Billion CHF | -1.93% |
2018 | 48.15 Billion CHF | 1.01% |
2017 | 47.66 Billion CHF | -5.45% |
2016 | 50.41 Billion CHF | -3.9% |
2015 | 52.46 Billion CHF | -3.0% |
2014 | 54.08 Billion CHF | 32.15% |
2013 | 40.92 Billion CHF | -14.87% |
2012 | 48.07 Billion CHF | 2.09% |
2011 | 47.09 Billion CHF | -4.59% |
2010 | 49.35 Billion CHF | -24.24% |
2009 | 65.15 Billion CHF | 192.59% |
2008 | 22.26 Billion CHF | -10.49% |
2007 | 24.87 Billion CHF | -9.87% |
2006 | 27.6 Billion CHF | -0.08% |
2005 | 27.62 Billion CHF | 11.46% |
2004 | 24.78 Billion CHF | -18.27% |
2003 | 30.32 Billion CHF | -20.67% |
2002 | 38.22 Billion CHF | -7.72% |
2001 | 41.41 Billion CHF | 10.45% |
2000 | 37.49 Billion CHF | -7.25% |
1999 | 40.43 Billion CHF | 22.28% |
1998 | 33.06 Billion CHF | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 62.91 Billion CHF | 0.0% |
2024 Q1 | 62.91 Billion CHF | 9.97% |
2023 Q2 | 54.02 Billion CHF | 0.0% |
2023 FY | 57.2 Billion CHF | 1.9% |
2023 Q3 | 57.2 Billion CHF | 5.88% |
2023 Q4 | 57.2 Billion CHF | 0.0% |
2023 Q1 | 54.02 Billion CHF | -3.76% |
2022 Q4 | 56.13 Billion CHF | 0.0% |
2022 FY | 56.13 Billion CHF | -12.25% |
2022 Q1 | 57.79 Billion CHF | -9.66% |
2022 Q2 | 57.79 Billion CHF | 0.0% |
2022 Q3 | 56.13 Billion CHF | -2.86% |
2021 Q4 | 63.97 Billion CHF | 0.0% |
2021 Q3 | 63.97 Billion CHF | 37.71% |
2021 Q2 | 46.45 Billion CHF | 0.0% |
2021 Q1 | 46.45 Billion CHF | 0.19% |
2021 FY | 63.97 Billion CHF | 37.97% |
2020 Q1 | 45.54 Billion CHF | -3.55% |
2020 FY | 46.36 Billion CHF | -1.82% |
2020 Q3 | 46.36 Billion CHF | 1.79% |
2020 Q4 | 46.36 Billion CHF | 0.0% |
2020 Q2 | 45.54 Billion CHF | 0.0% |
2019 Q3 | 47.22 Billion CHF | -3.97% |
2019 Q4 | 47.22 Billion CHF | 0.0% |
2019 FY | 47.22 Billion CHF | -1.93% |
2019 Q2 | 49.17 Billion CHF | 0.0% |
2019 Q1 | 49.17 Billion CHF | 2.13% |
2018 Q1 | 48.02 Billion CHF | 0.74% |
2018 Q3 | 48.15 Billion CHF | 0.27% |
2018 FY | 48.15 Billion CHF | 1.01% |
2018 Q2 | 48.02 Billion CHF | 0.0% |
2018 Q4 | 48.15 Billion CHF | 0.0% |
2017 Q4 | 47.66 Billion CHF | 0.0% |
2017 FY | 47.66 Billion CHF | -5.45% |
2017 Q3 | 47.66 Billion CHF | 2.36% |
2017 Q2 | 46.56 Billion CHF | 0.0% |
2017 Q1 | 46.56 Billion CHF | -7.63% |
2016 Q2 | 53.43 Billion CHF | 0.0% |
2016 Q1 | 53.43 Billion CHF | 1.85% |
2016 Q3 | 50.41 Billion CHF | -5.64% |
2016 Q4 | 50.41 Billion CHF | 0.0% |
2016 FY | 50.41 Billion CHF | -3.9% |
2015 FY | 52.46 Billion CHF | -3.0% |
2015 Q2 | 49.67 Billion CHF | 0.0% |
2015 Q4 | 52.46 Billion CHF | 0.0% |
2015 Q3 | 52.46 Billion CHF | 5.6% |
2015 Q1 | 49.67 Billion CHF | -8.14% |
2014 Q1 | 42.48 Billion CHF | 3.81% |
2014 Q3 | 53.98 Billion CHF | 27.06% |
2014 Q2 | 42.48 Billion CHF | 0.0% |
2014 FY | 54.08 Billion CHF | 32.15% |
2014 Q4 | 54.08 Billion CHF | 0.19% |
2013 FY | 40.92 Billion CHF | -14.87% |
2013 Q2 | 43.34 Billion CHF | 0.0% |
2013 Q4 | 40.92 Billion CHF | 0.0% |
2013 Q3 | 40.92 Billion CHF | -5.57% |
2013 Q1 | 43.34 Billion CHF | -9.85% |
2012 Q4 | 48.07 Billion CHF | 0.0% |
2012 Q2 | 47.53 Billion CHF | 0.0% |
2012 FY | 48.07 Billion CHF | 2.09% |
2011 Q2 | 44.45 Billion CHF | 0.0% |
2011 FY | 47.09 Billion CHF | -4.59% |
2011 Q4 | 47.09 Billion CHF | 0.0% |
2010 FY | 49.35 Billion CHF | -24.24% |
2010 Q2 | 56.05 Billion CHF | 0.0% |
2010 Q4 | 49.35 Billion CHF | 0.0% |
2009 Q4 | 65.15 Billion CHF | 0.0% |
2009 Q2 | 71.28 Billion CHF | 0.0% |
2009 FY | 65.15 Billion CHF | 192.59% |
2008 Q2 | 21.51 Billion CHF | 0.0% |
2008 FY | 22.26 Billion CHF | -10.49% |
2008 Q4 | 22.26 Billion CHF | 0.0% |
2007 Q2 | 26.15 Billion CHF | 0.0% |
2007 FY | 24.87 Billion CHF | -9.87% |
2007 Q4 | 24.87 Billion CHF | 0.0% |
2006 Q4 | 27.6 Billion CHF | 0.0% |
2006 FY | 27.6 Billion CHF | -0.08% |
2005 FY | 27.62 Billion CHF | 11.46% |
2004 FY | 24.78 Billion CHF | -18.27% |
2003 FY | 30.32 Billion CHF | -20.67% |
2002 FY | 38.22 Billion CHF | -7.72% |
2001 FY | 41.41 Billion CHF | 10.45% |
2000 FY | 37.49 Billion CHF | -7.25% |
1999 FY | 40.43 Billion CHF | 22.28% |
1998 FY | 33.06 Billion CHF | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
AstraZeneca PLC | 61.86 Billion USD | 7.533% |
Bristol-Myers Squibb Company PFD CONV 2 | 65.67 Billion USD | 12.896% |
CSPC Pharmaceutical Group Limited | 1.53 Billion USD | -3615.06% |
Clarus Therapeutics Holdings, Inc. | 67.62 Million USD | -84488.996% |
Novartis AG | 53.19 Billion USD | -7.538% |
PT Kalbe Farma Tbk. | 255.94 Million USD | -22250.898% |